Authors:
Braithwaite JM. Morris RW. Economides DL.
Institution:
University Department, Obstetrics and Gynaecology, Royal Free Hospital School Medicine,London NW3 2QE; United Kingdom.
Title:
Nuchal translucency measurements: Frequency distribution and changes with gestation in a general population.
Source:
British Journal of Obstetrics and Gynaecology. Vol 103(12) (pp201-1204), 1996.
Abstract:
Objectives:
To investigate nuchal translucency variation with crown-rump length (CRL) in the first trimester in normal fetuses.
Design:
A prospective Observational study
Setting:
Department of obstetrics in a London teaching hospital.
Participants:
One thousand seven hundred and seven pregnant women (1685 singleton and 22 twin pregnancies) with chromosomally normal fetuses between 9(+0) and 14(+6) weeks of gestation were recruited sequentially from a dating scan clinic. Nuchal translucency was measured in 94.9% by transabdominal sonography (TAS) and by transvaginal sonography (TVS) if difficulty was encountered with TAS (5.1%). Nuchal translucency measurement was repeated in 136 fetuses: the first scan between 9(+0)-11(+6) weeks and the second over 12 weeks of gestation.
Results:
Of this general population, 4.2% had a nuchal translucency (NT) measurement<= 2.5 mm, but this proportion varied significantly between gestational age groups (P = 0.011). The repeatability coefficients for NT measurements were 0.44 mm and 0.23 mm for TAS and TVS, respectively. The cross-sectional data demonstrate an increase in nuchal translucency measurement between 9 and 12 weeks of gestation and then a decrease at 13-14 weeks. This relation is best modelled using the Quadratic e quation: log10 (NT) = -1.03 + (0.0314 x CRL)-(2.20 x 10-4 x CRL2). Longitudinal data confirmed an increase of nuchal translucency measurements with increasing gestation.
Conclusion:
Nuchal translucency measurements increase significantly with increasing gestation. The use of a single threshold nuchal translucency measurement throughout the first trimester is inappropriate. We propose reference ranges of nuchal translucency measurements with gestation, aiming to improve the performance of nuchal translucency screening for chromosomal abnormalities.
Please click on the required question.
- 1 What does the term abortion mean?
- 2 What are the legal criteria that permit doctors to terminate a pregnancy in the UK?
- 3 How could we tell if there is a substantial risk that if the child were born it would suffer from such physical abnormalities as to be seriously handicapped - e.g. Down Syndrome?
- 3A What is Tay Sachs and should we test for it?
- 4 How prevalent is pregnancy termination?
- 5 Why do unwanted pregnancies occur?
- 6 I think I may be pregnant and I do not want to have a baby now. What should I do?
- 7 Should I terminate my pregnancy for social reasons?
- 8 How can my pregnancy be terminated?
- 9 What does a suction (surgical) termination of pregnancy involve?
- 10 What is a medical abortion?
- 11 What will happen to me if I have a medical abortion?
- 12 How do medical and surgical pregnancy termination compare?
- 13 What are the chances of medical termination failing?
- 14 What are the risks of pregnancy termination?
- 15 Why is there debate about the ethics of pregnancy termination?
- 16 Support Groups.
- 17 Where can I obtain more information?
Thank you for choosing to visit us.
This is the personal website of David A Viniker MD FRCOG, Consultant Obstetrician and Gynaecologist at Whipps Cross University Hospital, London - Specialist Interests - Reproductive Medicine including Infertility, PCOS, PMS, Menopause and HRT.
I do hope that you find the answers to your women's health questions in the patient information and medical advice provided.
